Feb 20, 2020
Researchers Say Extended Antidepressant Use Creates Physical Dependence
Dec 26, 2019
Luye Pharma Submits New Drug Application in the U.S. for Its Antidepressant Drug LY03005
Nov 14, 2019
VistaGen Reports Topline Phase 2 Results for AV-101 as an Adjunctive Treatment of Major Depressive Disorder
Oct 28, 2019
Biohaven Completes Enrollment In Phase 3 Generalized Anxiety Disorder (GAD) Trial Of Troriluzole
Oct 22, 2019
Actify Launches New 360-Degree Treatment Model for People Living with Depression and Anxiety Disorders
Aug 29, 2019
Depression Drugs Market to Generate US$ 5000 Million Revenue by 2026, Online Pharmacies to Gain Market Share - TMR
May 16, 2019
Visiongain Report Claims there is Huge Potential within the $14bn Antidepressant and Anti-Anxiety Drugs Market
Mar 18, 2019
The Worldwide Antidepressant Market to 2024 - Emergence of Novel Biologics Bodes Well for Growth
Feb 20, 2019
Biohaven Enrolls First Patient In Phase 3 Generalized Anxiety Disorder (GAD) Trial Of Troriluzole
Jan 03, 2019
New Data Published in the International Journal of Neuropsychopharmacology Support that Rapastinel May Produce Rapid and Sustained Antidepressant Effects Through a Potentially Novel Mechanism of Action
Nov 21, 2018
Antidepressant Drugs Market to Reach $15.98 Bn by 2023, Globally at 2.1% CAGR, Says Allied Market Research
Oct 11, 2018
Global Antidepressant Drugs Market Forecast 2018-2024: Key Players are Novartis, Allergan, Elli Lilly and Co, AstraZeneca, GSK, Otsuka and Johnson & Johnson
Jul 23, 2018
Allergan Receives FDA Fast Track Designation for AGN-241751 for the Treatment of Major Depressive Disorder (MDD)
May 22, 2018
Depression Drugs Market to be Worth US$ 5000 Mn by 2026 | TMR
May 02, 2018
TRINTELLIX® (vortioxetine) Prescribing Information Now Includes New Data Showing Improvement in Processing Speed, an Important Aspect of Cognitive Function in Acute Major Depressive Disorder (MDD)
Aug 07, 2017
Diabetic Neuropathy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025